Previous Close | 105.30 |
Open | 105.01 |
Bid | 106.60 x 900 |
Ask | 106.62 x 800 |
Day's Range | 104.88 - 107.02 |
52 Week Range | 68.53 - 107.15 |
Volume | |
Avg. Volume | 2,041,687 |
Market Cap | 26.256B |
Beta (5Y Monthly) | 0.77 |
PE Ratio (TTM) | 174.64 |
EPS (TTM) | 0.61 |
Earnings Date | Jan 31, 2024 - Feb 05, 2024 |
Forward Dividend & Yield | 2.00 (1.90%) |
Ex-Dividend Date | Dec 29, 2023 |
1y Target Est | 108.75 |
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Inari Medical's (NARI) latest announcement of first patient enrollment in PEERLESS II RCT is likely to aid in changing guidelines in treating intermediate-risk PE patients globally.
In the realm of stock market movements, insider trading activity is often a significant indicator for investors.